Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma

Luminescence

Volumn 15, Issue 6, 2000, Pages 399-407

  Pettersson, Kim ^a   Katajamäki, Taina ^b   Irjala, Kerttu ^b   Leppanen, Virpi ^c   Majamaa Voltti, Kirsi ^d   Laitinen, Päivi ^d  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Innotrac Diagnostics Oy   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiac troponin I; CK MB; Dry reagents; Immunoassay; Myocardial infarction; Myoglobin; Point of care (POC); Time resolved fluorometry; Whole blood

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; MYOGLOBIN; TROPONIN I;

ARTICLE; BLOOD; BLOOD ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; EVALUATION; FLUOROIMMUNOASSAY; HEART INFARCTION; HUMAN; METHODOLOGY; PLASMA; SENSITIVITY AND SPECIFICITY; STATISTICS;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CREATINE KINASE; FLUOROIMMUNOASSAY; HUMANS; INDICATORS AND REAGENTS; MYOCARDIAL INFARCTION; MYOGLOBIN; PLASMA; SENSITIVITY AND SPECIFICITY; TROPONIN I;

ASSAYS; BLOOD; CARDIOLOGY; FLUOROPHORES; IMMUNOLOGY;

'DRY' [; CARDIAC TROPONIN I; CK-MB; DRY REAGENT; IMMUNOASSAY; MYOCARDIAL INFARCTION; MYOGLOBIN; POINT OF CARE; POINT-OF-CARE; TIME-RESOLVED FLUOROMETRY; WHOLE BLOOD;

CHELATION;

EID: 0034330042     PISSN: 15227235     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-7243(200011/12)15:6<399::AID-BIO627<3.0.CO;2-3     Document Type: Article

References (15)

1. Price CP, Hicks JM. Point-of-care testing. In Point-of-care Testing, Price CP, Hicks JM (eds). AACC Press: Washington, 1999; 3-16.
2. Keffer J. Health economics aspects of point-of-care testing. In Point-of-care Testing, Price CP, Hicks JM (eds). AACC Press: Washington, 1999; 233-48.
3. Newby LK, Gibler WB, Ohman EM, Christensson RH. Biochemical markers in suspected acute myocardial infarction: the need for early assessment. Clin. Chem. 1995; 41: 1263-1265.
4. Wu AHB. Point-of-care testing and the patient with chest pain. In Point-of-care Testing, Price CP, Hicks JM (eds). AACC Press: Washington, 1999; 429-448.
5. Christensson RH. Point-of-care testing for cardiac markers. In Cardiac Markers, Wu AHB (ed.) Humana: Totowa, 1998; 259-280.
6. Price CP, Thorpe GH. Disposable analytical devices for point-of-care testing. In Point-of-care Testing, Price CP, Hicks JM (eds). AACC Press: Washington, 1999; 19-40.
7. Lövgren T, Meriö L, Mitrunen K, Mäkinen M-L, Mäkelä M, Blomberg K, Palenius T, Pettersson K. One-step all-in-one dry reagent immunoassays using a fluorescent europium chelate label and time-resolved fluorometry. Clin. Chem. 1996; 42: 1196-1201.
8. Takalo H, Hänninen E, Kankare J. Luminescence of europium (III) chelates with 4-(arylethynyl)pyridines as ligands. Helv. Chim. Acta. 1993; 76: 877-883.
9. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, Nø rgaard-Pedersen B. Double-monoclonal immunofluorometric assays for pregnancy associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first trimester maternal serum screening for Down's syndrome. Clin. Chem. 1997; 43: 2323-2332.
10. Lövgren T, Mitrunen K, Väänänen K, Vuori J, Pettersson K. Rapid time-resolved immunoassay of myoglobin in whole bloods samples for early detection of acute myocardial infarction and cardiac reperfusion. In Proceedings of the XVI International Congress of Clinical Chemistry, Martin SM, Halloran SP (eds). London, 1996; 495.
11. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, Lövgren T, Bulargina TV, Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin. Chem. 1998; 44: 2433-2440.
12. Newman DJ, Olabiran Y, Bedzyk DW, Chance S, Gorman EG, Price CP. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I. Clin. Chem. 1999; 45: 822-828.
13. Katrukha A, Bereznikowa A, Pettersson K. New approach to standardization of human cardiac troponin I (cTnI). Scand. J. Clin. Lab. Invest. Suppl. 1999; 230: 124-127.
14. Gerhardt W, Nordin G, Herbert A-K, Linå ker Burzell B, Isaksson A, Gustavsson E, Haglund S, Müller-Bardorff M, Katus HA. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin. Chem. 2000; 46: 817-821.
15. Lövgren T, Pettersson K. Time-resolved fluoroimmunoassay, advantages and limitations. In Luminescence Immunoassay and Molecular Applications, Van Dyke K, Van Dyke R (eds). CRC Press: Boca Raton, FL, 2000; 223-253.